Trade Setup Buy Target $316.83 Sell Target $365.11 Trailing Stop 20% Coca-Cola Consolidated, Inc., together with its subsidiaries, produces, markets, and distributes nonalcoholic beverages, primarily products of The Coca-Cola Company in the United States. The company offers sparkling beverages, including carbonated beverages; and still beverages, such as energy products, as well as noncarbonated beverages comprising […]
Read MoreBuy Target $2.04 Sell Target $2.54 Trailing Stop 20% Hecla Mining Company, together with its subsidiaries, discovers, acquires, develops, and produces precious and base metal properties worldwide. The company offers lead, zinc, and bulk flotation concentrates to custom smelters and brokers; and unrefined gold and silver bullion bars to precious metals traders. It owns 100% […]
Read MoreBuy Target $1.22 Sell Target $1.44 Trailing Stop 20% Kelso Technologies Inc., designs, engineers, produces, markets, and distributes various products for the rail sector in the United States and Canada. The company’s products are used to reduce the risk of environmental harm due to non-accidental events in the transportation of hazardous commodities. It offers bottom […]
Read MoreBuy Target $7.95 Sell Target $9.85 Trailing Stop 20% Glu Mobile Inc. develops, publishes, and markets a portfolio of free-to-play mobile games for the users of smartphones and tablet devices. The company publishes titles primarily in four genres, including home décor, sports and action, fashion and celebrity, and time management. It creates games based on […]
Read MoreTrade Setup Buy Target $2.98 Sell Target $3.32 Trailing Stop 20% Alithya Group Inc. provides strategy and digital technology services in Canada, the United States, and Europe. The company’s digital strategy and transformation services include strategic consulting and organizational change, governance and strategic alignment, investment management, collaborative management and co-management, business and enterprise architecture, managing […]
Read MoreBuy Target $2.78 Sell Target $3.24 Trailing Stop 20% AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company also develops ZALVISO, a […]
Read MoreTrade Setup Buy Target $8.71 Sell Target $10.45 Trailing Stop 20% Tilly’s, Inc. retails casual apparel, footwear, and accessories for young men and women, and boys and girls in the United States. Its apparel merchandise includes tops, outerwear, bottoms, and dresses; and accessories merchandise comprises backpacks, hats, sunglasses, headphones, handbags, watches, jewelry, and others.
Read MoreTrade Setup Buy Target $16.25 Sell Target $20.67 Trailing Stop 20% Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marijuana for Medical Purposes Regulations (MMPR). The firm typically […]
Read MoreBuy Target $3.92 Sell Target $4.89 Trailing Stop 20% Lantronix, Inc. provides secure data access and management solutions for Internet of Things (IoT) assets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific Japan. The company’s IoT products include IoT gateways, which provide secure connectivity and the ability to add integrated device […]
Read MoreTrade Setup Buy Target $9.27 Sell Target $10.93 Trailing Stop 20% Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurer worldwide. The company offers various property reinsurance products and services, including automobile physical damage; personal lines, such as homeowners’ insurance; and commercial lines. It also provides casualty reinsurance products and […]
Read MoreBuy Target $1.22 Sell Target $1.41 Trailing Stop 20% BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for […]
Read MoreTrade Setup Buy Target $3.49 Sell Target $4.16 Trailing Stop 20% Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a […]
Read MoreTrade Setup Buy Target $1.52 Sell Target $1.68 Trailing Stop 20% vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops orally administered small molecule drug candidates to fill unmet medical needs. The company is developing Azeliragon, an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase II/III […]
Read MoreTrade Setup Buy Target $5.79 Sell Target 1 $6.72 Trailing Stop 20% Sell Target 2 $7.36 GoPro, Inc. develops and sells cameras, drones, and mountable and wearable accessories in the United States and internationally. The company offers HERO7, a cloud-connected line of camera; Fusion, a waterproof spherical camera; GoPro Plus, a cloud-based storage solution that […]
Read MoreTrade Setup Buy Target $11.27 Sell Target $12.83 Trailing Stop 20% Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United States.
Read More